Group One Trading
DNA icon

Group One Trading’s Ginkgo Bioworks DNA Stock Holding History

Group One Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.4K Sell
7,400
-15,800
-68% -$131K ﹤0.01% 5332
2025
Q4 		$193K Sell
23,200
-12,400
-35% -$134K ﹤0.01% 4404
2025
Q3 		$519K Buy
35,600
+14,600
+70% +$175K ﹤0.01% 3665
2025
Q2 		$236K Sell
21,000
-6,000
-22% -$46.5K ﹤0.01% 4164
2025
Q1 		$154K Sell
27,000
-4,600
-15% -$46.9K ﹤0.01% 4236
2024
Q4 		$310K Sell
31,600
-73,900
-70% -$633K ﹤0.01% 3558
2024
Q3 		$860K Buy
105,500
+93,790
+801% +$940K ﹤0.01% 2431
2024
Q2 		$157K Sell
11,710
-3,980
-25% -$119K ﹤0.01% 3602
2024
Q1 		$728K Sell
15,690
-4,588
-23% -$237K ﹤0.01% 2377
2023
Q4 		$1.37M Buy
20,278
+235
+1% +$14.4K ﹤0.01% 2169
2023
Q3 		$1.45M Buy
20,043
+12,935
+182% +$1.03M ﹤0.01% 1912
2023
Q2 		$529K Buy
7,108
+4,463
+169% +$264K ﹤0.01% 2955
2023
Q1 		$141K Sell
2,645
-4,920
-65% -$312K ﹤0.01% 3991
2022
Q4 		$511K Sell
7,565
-2,470
-25% -$227K ﹤0.01% 3024
2022
Q3 		$1.25M Buy
10,035
+3,785
+61% +$451K ﹤0.01% 2331
2022
Q2 		$595K Sell
6,250
-20,323
-76% -$2.48M ﹤0.01% 3264
2022
Q1 		$4.28M Sell
26,573
-21,507
-45% -$4.19M ﹤0.01% 1678
2021
Q4 		$16M Buy
48,080
+41,520
+633% +$19.7M 0.01% 790
2021
Q3 		$3.04M Buy
+6,560
New +$3.19M ﹤0.01% 2226

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's DNA Position: Q1 2026 in Review

Group One Trading reduced its Ginkgo Bioworks (DNA) stake by 58% in Q1 2026, selling an estimated $70.2K and leaving 6,017 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5498.

Group One Trading first reported a position in DNA in Q2 2022 and has held it in 13 quarters since. The position peaked at $1.07M in Q1 2024. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Group One Trading held 6,017 shares of Ginkgo Bioworks worth $36.9K as of Q1 2026.
  • Group One Trading sold 8,442 Ginkgo Bioworks shares in Q1 2026, an estimated $70.2K.
  • Ginkgo Bioworks made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5498 holding.
  • Group One Trading first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 13 quarters since.
  • Group One Trading's Ginkgo Bioworks position peaked at $1.07M in Q1 2024.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.